Akinlonu Adedoyin A, Alonso Alvaro, Mene-Afejuku Tuoyo O, Lopez Persio, Kansara Tikal, Ola Olatunde, Mushiyev Savi, Pekler Gerald
Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, USA.
Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Cureus. 2023 Jun 12;15(6):e40298. doi: 10.7759/cureus.40298. eCollection 2023 Jun.
Background Obesity and illicit drugs are independent risk factors for developing heart failure (HF). However, recent studies have suggested that patients who already have HF and are obese have better clinical outcomes. We aim to study the effect of cocaine use on this obesity paradox phenomenon as it pertains to HF readmissions. Methodology In a retrospective chart analysis, we reviewed patients with a diagnosis of HF with reduced ejection fraction (HFrEF) admitted to Metropolitan Hospital in New York. We studied the association between body mass index (BMI) categories, namely, non-obese (<30 kg/m) and obese (≥30 kg/m), cocaine use, and the primary outcome (time to readmission for HF within 30 days after discharge). The interaction between cocaine and obesity status and its association with the primary outcome was also assessed. Results A total of 261 patients were identified. Non-obese status and cocaine use were associated with an increased hazard of readmission in 30 days (hazard ratio (HR) = 2.28, p = 0.049 and HR = 3.12, p = 0.004, respectively). Furthermore, cocaine users who were non-obese were over six times more likely to be re-admitted in 30 days compared to non-cocaine users who were obese (HR = 6.45, p = 0.0002). Conclusions Non-obese status and continued use of cocaine have a negative additive effect in impacting HF readmissions.
肥胖和非法药物是发生心力衰竭(HF)的独立危险因素。然而,最近的研究表明,已患有HF的肥胖患者具有更好的临床结局。我们旨在研究使用可卡因对这种与HF再入院相关的肥胖悖论现象的影响。方法:在一项回顾性病历分析中,我们回顾了纽约大都会医院收治的射血分数降低的心力衰竭(HFrEF)患者。我们研究了体重指数(BMI)类别,即非肥胖(<30 kg/m²)和肥胖(≥30 kg/m²)、可卡因使用情况与主要结局(出院后30天内HF再入院时间)之间的关联。还评估了可卡因与肥胖状态之间的相互作用及其与主要结局的关联。结果:共确定了261例患者。非肥胖状态和可卡因使用与30天内再入院风险增加相关(风险比(HR)分别为2.28,p = 0.049和HR = 3.12,p = 0.004)。此外,非肥胖的可卡因使用者在30天内再次入院的可能性是非可卡因使用者且肥胖者的六倍多(HR = 6.45,p = 0.0002)。结论:非肥胖状态和持续使用可卡因在影响HF再入院方面具有负面累加效应。